|
⚲
|
| Keyboard |
| Lebwohl David
✚
|
|
|---|---|
| CIK # | 0001810882 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001810882] | |
| 4 | [0001810882] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lebwohl David | |
| Intellia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 9,943 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 14,204 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 11,903 | $9.21 | 109,627 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-03-01 | Grant | 43,200 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-03-01 | Grant | 61,714 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-03 | Sell | 9,557 | $12.18 | 116,404 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-01 | Option exercise | 3,189 | ||
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit · derivative
|
2025-01-01 | Option exercise | 3,189 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-03-01 | Grant | 38,701 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2024-03-01 | Grant | 55,855 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-01-03 | Sell | 5,843 | $29.46 | 172,135 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-01-01 | Option exercise | 3,187 | ||
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit · derivative
|
2024-01-01 | Option exercise | 3,187 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2023-03-01 | Grant | 43,342 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2023-03-01 | Grant | 30,674 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2023-01-04 | Sell | 2,574 | $37.21 | 95,779 |
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit · derivative
|
2023-01-01 | Option exercise | 3,187 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2023-01-01 | Option exercise | 3,187 | ||
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 13,816 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2022-03-01 | Grant | 13,816 | $0.00 | |
| showing 20 of 54 most recent transactions | |||||